Global Glycobiology/Glycomics Market is Likely to Grow at a CAGR Value of 14.40 % By 2028

The global glycobiology/glycomics market size was worth USD 962.40 million in 2021 and is estimated to grow to USD 2157.30 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.40 percent over the forecast period. The report analyzes the glycobiology/glycomics market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the glycobiology/glycomics market.

Glycomics, also known as glycobiology, is the study of the structure, biology, and function of saccharides, which are extensively dispersed in nature and are classified as glycans. Glycans can be present in all living things. Glycobiology is a fast-developing biological discipline of interest in biotechnology, healthcare, and fundamental science sectors. In eukaryotic cells, most proteins are updated after translation. Glycan attachment is one of the most common alterations for cell survival. Glycosylation may be classified into two types. 1) N-linked glycosylation occurs when a glycan is coupled to asparagine. 2) O-linked glycosylation: the attachment of a glycan to a serine or threonine. Glycoproteins and glycolipids in the cell membrane create a carbohydrate-coated surface that allows cells to communicate with the external environment.

Rising R&D spending, technical developments in glycomics equipment, and increased use of glycomics in immunology, biochemistry, and cancer are key drivers likely to fuel global glycobiology/glycomics market revenue growth during the forecast period. Other important drivers predicted to drive market revenue growth include the rapid expansion of the biotechnology && pharmaceutical industries throughout the world, increased use of glycomics in drug discovery and development, and rising demand for precision medicine. Glycans are the most numerous and architecturally diverse family of molecules, consisting of sequences of carbohydrates attached to lipids and proteins. Glycomics, also known as glycobiology, studies glycan structure, biology, and function in any cell or organism. Glycomics is also concerned with glycans' genetic, physiological, and pathologic properties. Recent advances in glycomics research have assisted researchers and scientists in better understanding the extent and size of glycans' functional activities and their influence on human illness conditions. This is projected to considerably contribute to the market's revenue growth in the future.

The global glycomics/glycobiology market is segregated based on products, applications, end-user, and regions. Based on product, the market is segmented into enzymes, instruments, carbohydrates, kits, reagents, and chemicals. Instruments segment dominated the market in 2021. Based on application, the market is classified into disease diagnostics, drug discovery & development, and others. Drug discovery and development held the largest share in the market in 2021. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, and academic research institutes. The academic research institutes segment dominated in 2021.

The global glycobiology/glycomics market is divided into geographic regions: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Over the estimated period, North America is expected to be the fastest expanding market. Increased investments in glycomics research, expanding R&D investment prospects in the pharmaceutical sector for medication development, and the presence of all major market competitors are factors projected to spur the regional market growth.

Due to untapped market prospects, Asia Pacific is predicted to be the second fastest-growing regional market throughout the projection period. The region's glycomics industry has grown dramatically as a result of the region's developing pharmaceutical and biopharmaceutical sectors. Furthermore, Contract Research Organizations (CROs) investments in drug discovery and biologics manufacturing are likely to drive growth in the Asia Pacific market.

Key players in the global glycobiology/glycomics market include Agilent Technologies, Waters Corporation, Lectenz Bio, Takara Bio, Thermo Fisher Scientific, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation, and S Bio.

Browse the full “Glycobiology/Glycomics Market By Product (Enzymes, Instrument, Carbohydrates, Kits, Reagents and Chemicals, Others), By Application (Disease Diagnostics, Drug Discovery & Development, Others), By End User (Pharmaceutical & Biotechnology Companies, Clinical Laboratories, Academic Research Institutes), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/glycomics-glycobiology-industry

Global Glycobiology/glycomics Market is segmented as follows:

By Product

• Enzymes
• Instrument
• Carbohydrates
• Kits
• Reagents and Chemicals
• Others

By Application

• Disease Diagnostics
• Drug Discovery and Development
• Others

By End-User

• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories
• Academic Research Institutes

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com